Stay updated on Sotatercept in PAH High-Risk Mortality Clinical Trial
Sign up to get notified when there's something new on the Sotatercept in PAH High-Risk Mortality Clinical Trial page.

Latest updates to the Sotatercept in PAH High-Risk Mortality Clinical Trial page
- Check5 days agoChange DetectedThe revision tag on the page changed from v3.6.2 to v3.6.3. This indicates a newer version of the page documentation, likely reflecting minor editorial updates without changing study details.SummaryDifference0.0%

- Check12 days agoChange DetectedA new Revision: v3.6.2 tag was added, replacing the previous v3.6.0 in the page's revision history. This reflects a minor update to the page's documentation/versioning.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page adds a recruitment-status notice ('No longer looking for participants') and several new help sections (How to Read a Study Record, Common Questions, How to Join a Study), and updates the Intervention/Treatment heading styling. It also removes the old 'Intervention / Treatment' heading and replaces the revision footer with 'Revision: v3.6.0'.SummaryDifference0.3%

- Check33 days agoChange DetectedA new revision tag 'Revision: v3.5.5' is now displayed, replacing the previous 'Revision: v3.5.4'. This indicates a newer build of the page's interface rather than changes to study content.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page now includes a Plain Language Summary to provide a non-technical overview of the study. New date entries (2026-05-29, 2026-05-27, 2026-05) were added and older date entries (2026-03-02, 2026-02-09, 2026-02) were removed.SummaryDifference0.2%

- Check48 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing Revision: v3.5.3, indicating a new published version of the page.SummaryDifference0.0%

Stay in the know with updates to Sotatercept in PAH High-Risk Mortality Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotatercept in PAH High-Risk Mortality Clinical Trial page.